HANNOVER RE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.68 USD | +1.52% |
|
+4.58% | +7.10% |
| Apr. 17 | HANNOVER RUECKVERSICHERUNG AG : JP Morgan keeps its Buy rating | ZD |
| Apr. 15 | HANNOVER RUECKVERSICHERUNG AG : JP Morgan reaffirms its Buy rating | ZD |
Strengths
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Reinsurance
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +7.10% | 30.82B | - | ||
| +21.41% | 65.61B | A- | ||
| +8.30% | 16.64B | B- | ||
| +15.18% | 11.94B | C | ||
| +8.28% | 2.14B | - | C+ | |
| +7.16% | 1.78B | - | ||
| +51.61% | 670M | C+ | ||
| -12.42% | 616M | C- | ||
| +14.71% | 464M | - | C+ | |
| +16.86% | 379M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- HNR1 Stock
- HVRRY Stock
- Ratings Hannover Re